Home > Media > Group News > Media News 2005
 
Media News 2005

Group News
2005
 
Dec, 23 Roche grants Tamiflu sub-license to India´s Hetero Drugs to make flu medicine for India and developing countries more..
Dec, 22 U.S. Food and Drug Administration extends prophylaxis indication for Tamiflu to children between 1 to 12 years of age more..
Dec, 22 Statement - In response to paper by de Jong et al., published in the NEJM, 22 December 2005 more..
Dec, 16 Roche announces successful completion of four pivotal Phase III clinical trials for CERA more..
Dec, 15 Tamiflu gains positive opinion in Europe and Switzerland for prevention of influenza in children 1 to 12 years more..
Dec, 14 Changes on Corporate Executive Committee and Board of Directors of Roche more..
Dec, 13 Roche and SystemsX collaborate in diabetes research more..
Dec, 12 MabThera maintenance therapy dramatically improves survival for patients with lymphoma  more..
Dec, 12 Roche update on Tamiflu global supply to meet future world demands - from partnerships to regional sub-licenses more..
Dec, 1 Food, clothing and education for AIDS orphans in Malawi more..
Nov, 30 Roche and BioCryst collaborate on clinical compound BCX-4208 for transplantation and autoimmune diseases more..
Nov, 25 Roche confirms ability to supply pandemic Tamiflu to the people of Taiwan more..
Nov, 19 FDA Advisory Committee Affirms Safety of Tamiflu in Children more..
Nov, 17 Actemra monotherapy significantly slows down damage to joints in patients with early aggressive rheumatoid arthritis more..
Nov, 16 Bonviva intravenous injection for postmenopausal osteoporosis confirmed effective over 2 years more..
Nov, 16 MabThera - a unique approach providing lasting benefits for patients with rheumatoid arthritis more..
Nov, 16 Roche and Gilead end dispute on influenza drug Tamiflu more..
Nov, 11 Early results show Pegasys working where Peg-Intron has failed more..
Nov, 7 Roche announces further progress in Tamiflu production expansion more..
Nov, 3 Tarceva receives approval for pancreatic cancer in the United States more..
Nov, 2 Xeloda now shown to extend survival for patients with pancreatic cancer more..
Nov, 1 Roche and Protein Design Labs to jointly develop daclizumab in transplant maintenance therapy more..
Oct, 19 Roche continues to post strong growth through third quarter more..
Oct, 18 Further expansion of Tamiflu manufacturing capacity more..
Oct, 11 Roche Diagnostics to co-develop IT-enabled prototype psychiatric pharmacogenomics tool more..
Oct, 7 Roche becomes founding member of ICRC Corporate Support Group more..
Oct, 7 Roche launches novel system for High-throughput DNA Sequencing more..
Sep, 21 Tarceva approved in Europe for lung cancer more..
Sep, 19 Roche reselected for inclusion in Dow Jones Sustainability and FTSE4Good Index series more..
Sep, 19 Once-monthly oral Bonviva approved for postmenopausal osteoporosis in Europe more..
Sep, 14 New Herceptin results confirm impressive reduction in risk of cancer returning in women with aggressive form of early-stage breast cancer more..
Sep, 13 Pegasys plus Ribavirin awarded priority review status by Japanese Regulatory Agency more..
Sep, 12 Roche announces settlement agreement with Promega more..
Sep, 8 Once-monthly oral Bonviva approved for postmenopausal osteoporosis in Switzerland more..
Sep, 6 Roche files first rheumatoid arthritis indication for MabThera in Europe more..
Aug, 26 Hanspeter Kyburz to be commissioned to write the third Roche Commissions composition more..
Aug, 24 Roche donates 3 million treatments of antiviral Tamiflu to the WHO for use in an influenza pandemic more..
Jul, 26 Acquisition of GlycArt Biotechnology completed more..
Jul, 20 Roche posts very strong interim results more..
Jul, 19 Roche files new indication for Tamiflu in Europe for prevention of influenza in children 1 to 12 years more..
Jul, 19 Roche acquires Swiss based GlycArt Biotechnology to strengthen expertise in therapeutic antibody research  more..
Jun, 29 US Court of Appeals decides in favour of Roche on Empagran case more..
Jun, 28 Xenical gains European approval for use in young people more..
Jun, 27 Bonviva, the first once-monthly oral tablet for osteoporosis, receives positive opinion in Europe more..
Jun, 27 Tarceva receives positive opinion in EU for the treatment of patients with lung cancer more..
Jun, 15 FDA approves oral Xeloda for the adjuvant (after surgery) treatment of colon cancer more..
Jun, 9 New data confirm once-monthly oral treatment for osteoporosis is highly effective over two years more..
Jun, 7 Roche dedicates world´s largest PCR-manufacturing facility in New Jersey more..
May, 27 European approval for Roche´s new Invirase 500 mg tablet for the treatment of HIV more..
May, 12 Roche and 454 Life Sciences enter exclusive world-wide agreement more..
May, 2 Tarceva - supplemental new drug application filed in the US for treatment of pancreatic cancer more..
May, 2 FDA clears Roche´s new Accu-Chek Aviva blood glucose meter more..
Apr, 28 Herceptin - international study confirms significant improvement in disease-free survival for women with early-stage HER2-positive breast cancer more..
Apr, 26 Herceptin improves survival for the first time in women with early-stage HER2-positive breast cancer more..
Apr, 25 FDA approves Roche´s Cobas AmpliScreen Hepatitis B Test for use in screening Blood Donors more..
Apr, 19 Roche leads off in 2005 with impressive first quarter - pharmaceutical sales grow three times as fast as the global market more..
Apr, 18 Coagulation Self-Management with Roche´s CoaguChek S System can save lives more..
Apr, 15 Roche clinical trial registry and results database launched on www.roche-trials.com more..
Apr, 15 Avastin produces significant benefit in first-line metastatic breast cancer more..
Apr, 12 Roche and GlaxoSmithKline announce promotion agreement for Xenical in the US more..
Apr, 6 MabThera significantly improves symptoms in patients with rheumatoid arthritis who inadequately responded to anti-TNFα therapies more..
Apr, 1 Xeloda wins EU approval for adjuvant therapy in the treatment of colon cancer more..
Mar, 29 FDA approves once-monthly Boniva for osteoporosis more..
Mar, 22 New lung cancer medicine Tarceva receives first European approval more..
Mar, 15 Revolutionary cancer treatment Avastin now proven to extend life also for lung cancer patients more..
Feb, 28 Roche increases dividend by 21 percent more..
Feb, 28 US approves Pegasys and Copegus as first hepatitis C treatment for HIV patients more..
Feb, 25 Pegasys approved in the European Union for the treatment of chronic hepatitis B more..
Feb, 18 Xeloda: positive opinion in EU for treatment of colon cancer after surgery more..
Feb, 3 Pegasys combination therapy approved for the treatment of hepatitis C and HIV co-infection in Europe more..
Feb, 2 Annual Media Conference more..
Feb, 2 Roche in 2004: Net income doubled - further significant improvement in operating profitability and financial position more..
Jan, 21 Roche to launch publicly accessible databases for clinical trials more..
Jan, 21 Pegasys receives positive opinion in the European Union for the treatment of chronic hepatitis B more..
Jan, 14 Innovative Roche cancer medicine Avastin approved in EU more..
Jan, 12 Roche´s AmpliChip CYP450 Test receives FDA clearance more..
Jan, 3 Sale of Roche Consumer Health to Bayer completed more..
 

Deutsche Sprachversion     

English Version